Clinical Evidence

Our clinical programs are leading the field

Explore the scientific evidence supporting GRAIL’s multi-cancer early detection approach, including peer-reviewed publications and presentations at leading medical congresses. Together, these data highlight test performance, clinical utility, and progress toward transforming cancer screening.

Manuscripts

PLOS ONE

Analytical validation of a multi-cancer early detection test with cancer signal origin using a cell-free DNA–based targeted methylation assay

View Manuscript
Cancer Epidemiology

Surgical resection as a predictor of cancer-specific survival by stage at diagnosis and cancer type, United States, 2006–2015

View Manuscript
Cancer

Modeled residual current cancer risk after clinical investigation of a positive multi-cancer early detection test result

View Manuscript
Lancet Public Health

Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study

View Manuscript
BMC Cancer

Cancer incidence in immunocompromised patients: a single-center cohort study

View Manuscript
Nature

A DNA methylation atlas of normal human cell types

View Manuscript